Abstract
Reovirus has an inherent preference for replicating in cells with dysregulated growth factor signaling cascades that comprise Ras activation. Precisely how reovirus exploits the host cell Ras pathway is unclear, but there is evidence suggesting that activated Ras signaling is important for efficient viral protein synthesis. Defining the molecular mechanism of reovirus oncolysis will shed light on reovirus replication and important aspects of cellular transformation, Ras signaling cascades and regulation of protein translation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ahmed R, Canning WM, Kauffman RS, Sharpe AH, Hallum JV and Fields BN . (1981). Cell, 25, 325–332.
Anderson BD, Nakamura T, Russell SJ and Peng KW . (2004). Cancer Res., 64, 4919–4926.
Armstrong GD, Paul RW and Lee PW . (1984). Virology, 138, 37–48.
Balachandran S and Barber GN . (2004). Cancer Cell, 5, 51–65.
Barber GN, Jagus R, Meurs EF, Hovanessian AG and Katze MG . (1995). J. Biol. Chem., 270, 17423–17428.
Beattie E, Denzler KL, Tartaglia J, Perkus ME, Paoletti E and Jacobs BL . (1995). J. Virol., 69, 499–505.
Bergmann M, Romirer I, Sachet M, Fleischhacker R, Garcia-Sastre A, Palese P, Wolff K, Pehamberger H, Jakesz R and Muster T . (2001). Cancer Res., 61, 8188–8193.
Biederer C, Ries S, Brandts CH and McCormick F . (2002). J. Mol. Med., 80, 163–175.
Bischoff JR and Samuel CE . (1989). Virology, 172, 106–115.
Bos JL . (1989). Cancer Res., 49, 4682–4689.
Brostrom CO and Brostrom MA . (1998). Prog. Nucleic Acid Res. Mol. Biol., 58, 79–125.
Buday L . (1999). Biochim. Biophys. Acta, 1422, 187–204.
Campbell PM and Der CJ . (2004). Semin. Cancer Biol., 14, 105–114.
Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ and Der CJ . (1998). Oncogene, 17, 1395–1413.
Chappell JD, Duong JL, Wright BW and Dermody TS . (2000). J. Virol., 74, 8472–8479.
Chappell JD, Gunn VL, Wetzel JD, Baer GS and Dermody TS . (1997). J. Virol., 71, 1834–1841.
Chong KL, Feng L, Schappert K, Meurs E, Donahue TF, Friesen JD, Hovanessian AG and Williams BR . (1992). EMBO J., 11, 1553–1562.
Clemens MJ . (2004). Oncogene, 23, 3180–3188.
Clemens MJ and Bommer UA . (1999). Int. J. Biochem. Cell Biol., 31, 1–23.
Coffey MC, Strong JE, Forsyth PA and Lee PW . (1998). Science, 282, 1332–1334.
Cohen JA, Williams WV and Greene MI . (1988). Microbiol. Sci., 5, 265–270.
Cuddihy AR, Li S, Tam NW, Wong AH, Taya Y, Abraham N, Bell JC and Koromilas AE . (1999). Mol. Cell. Biol., 19, 2475–2484.
de Haro C, Mendez R and Santoyo J . (1996). FASEB J., 10, 1378–1387.
Dermody TS, Nibert ML, Bassel-Duby R and Fields BN . (1990). J. Virol., 64, 5173–5176.
Dermody TS, Nibert ML, Wetzel JD, Tong X and Fields BN . (1993). J. Virol., 67, 2055–2063.
Dobbelstein M . (2004). Curr. Top. Microbiol. Immunol., 273, 291–334.
Donze O, Dostie J and Sonenberg N . (1999). Virology, 256, 322–329.
Donze O, Jagus R, Koromilas AE, Hershey JW and Sonenberg N . (1995). EMBO J., 14, 3828–3834.
Duncan MR, Stanish SM and Cox DC . (1978). J. Virol., 28, 444–449.
Fantl WJ, Johnson DE and Williams LT . (1993). Annu. Rev. Biochem., 62, 453–481.
Farassati F, Yang AD and Lee PW . (2001). Nat. Cell Biol., 3, 745–750.
Feig LA . (2003). Trends Cell Biol., 13, 419–425.
Feig LA and Buchsbaum RJ . (2002). Curr. Biol., 12, R259–R261.
Grote D, Russell SJ, Cornu TI, Cattaneo R, Vile R, Poland GA and Fielding AK . (2001). Blood, 97, 3746–3754.
Hashiro G, Loh PC and Yau JT . (1977). Arch. Virol., 54, 307–315.
Heise C, Hermiston T, Johnson L, Brooks G, Sampson-Johannes A, Williams A, Hawkins L and Kirn D . (2000). Nat. Med., 6, 1134–1139.
Hirasawa K, Nishikawa SG, Norman KL, Alain T, Kossakowska A and Lee PW . (2002). Cancer Res., 62, 1696–1701.
Hirasawa K, Nishikawa SG, Norman KL, Coffey MC, Thompson BG, Yoon CS, Waisman DM and Lee PW . (2003). Cancer Res., 63, 348–353.
Jagus R, Joshi B and Barber GN . (1999). Int. J. Biochem. Cell Biol., 31, 123–138.
Janes PW, Daly RJ, deFazio A and Sutherland RL . (1994). Oncogene, 9, 3601–3608.
Kauffman RS, Ahmed R and Fields BN . (1983). Virology, 131, 79–87.
Khosravi-Far R, White MA, Westwick JK, Solski PA, Chrzanowska-Wodnicka M, Van AL, Wigler MH and Der CJ . (1996). Mol. Cell. Biol., 16, 3923–3933.
Koromilas AE, Roy S, Barber GN, Katze MG and Sonenberg N . (1992). Science, 257, 1685–1689.
Kumar A, Yang YL, Flati V, Der S, Kadereit S, Deb A, Haque J, Reis L, Weissmann C and Williams BR . (1997). EMBO J., 16, 406–416.
Malumbres M and Barbacid M . (2001). Nat. Rev. Cancer, 1, 222–231.
Malumbres M and Barbacid M . (2003). Nat. Rev. Cancer, 3, 459–465.
Marshall CJ . (1996). Curr. Opin. Cell Biol., 8, 197–204.
Martin-Blanco E . (2000). Bioessays, 22, 637–645.
Martuza RL . (2000). J. Clin. Invest., 105, 841–846.
Matsumoto K, Wassarman KM and Wolffe AP . (1998). EMBO J., 17, 2107–2121.
Mazumder B, Seshadri V, Imataka H, Sonenberg N and Fox PL . (2001). Mol. Cell Biol., 21, 6440–6449.
McCormick F . (2000). Semin. Cancer Biol., 10, 453–459.
Meurs EF, Galabru J, Barber GN, Katze MG and Hovanessian AG . (1993). Proc. Natl. Acad. Sci. USA, 90, 232–236.
Minich WB and Ovchinnikov LP . (1992). Biochimie, 74, 477–483.
Mundschau LJ and Faller DV . (1994). Biochimie, 76, 792–800.
Muster T, Rajtarova J, Sachet M, Unger H, Fleischhacker R, Romirer I, Grassauer A, Url A, Garcia-Sastre A, Wolff K, Pehamberger H and Bergmann M . (2004). Int. J. Cancer, 110, 15–21.
Norman KL, Coffey MC, Hirasawa K, Demetrick DJ, Nishikawa SG, DiFrancesco LM, Strong JE and Lee PW . (2002). Hum. Gene Ther., 13, 641–652.
Norman KL, Hirasawa K, Yang AD, Shields MA and Lee PW . (2004). Proc. Natl. Acad. Sci. USA, 101, 11099–11104.
Norman KL and Lee PW . (2000). J. Clin. Invest., 105, 1035–1038.
Nussbaum JM, Major M and Gunnery S . (2003). Cancer Lett., 196, 207–216.
O’Shea CC, Johnson L, Bagus B, Choi S, Nicholas C, Shen A, Boyle L, Pandey K, Soria C, Kunich J, Shen Y, Habets G, Ginzinger D and McCormick F . (2004). Cancer Cell, 6, 611–623.
Ouwens DM, de Ruiter ND, van der Zon GC, Carter AP, Schouten J, van der BC, Kooistra K, Bos JL, Maassen JA and van DH . (2002). EMBO J., 21, 3782–3793.
Overbeck AF, Brtva TR, Cox AD, Graham SM, Huff SY, Khosravi-Far R, Quilliam LA, Solski PA and Der CJ . (1995). Mol. Reprod Dev., 42, 468–476.
Pacitti AF and Gentsch JR . (1987). J. Virol., 61, 1407–1415.
Pawson T . (1994). Adv. Cancer Res., 64, 87–110.
Pawson T and Scott JD . (1997). Science, 278, 2075–2080.
Pecora AL, Rizvi N, Cohen GI, Meropol NJ, Sterman D, Marshall JL, Goldberg S, Gross P, O’Neil JD, Groene WS, Roberts MS, Rabin H, Bamat MK and Lorence RM . (2002). J. Clin. Oncol., 20, 2251–2266.
Pickering BM and Willis AE . (2005). Semin. Cell Dev. Biol., 16, 39–47.
Repasky GA, Chenette EJ and Der CJ . (2004). Trends Cell Biol., 14, 639–647.
Reuther GW and Der CJ . (2000). Curr. Opin. Cell Biol., 12, 157–165.
Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A and Downward J . (1997). Cell, 89, 457–467.
Rubin DH, Kornstein MJ and Anderson AO . (1985). J. Virol., 53, 391–398.
Samuel CE . (2001). Clin. Microbiol. Rev., 14, 778–809, table.
Schneider-Schaulies J . (2000). J. Gen. Virol., 81, 1413–1429.
Sieczkarski SB and Whittaker GR . (2005). Curr. Top. Microbiol. Immunol., 285, 1–23.
Sinkovics JG and Horvath JC . (2000). J. Clin. Virol., 16, 1–15.
Skabkin MA, Kiselyova OI, Chernov KG, Sorokin AV, Dubrovin EV, Yaminsky IV, Vasiliev VD and Ovchinnikov LP . (2004). Nucleic Acids Res., 32, 5621–5635.
Spirin AS . (1994). Mol. Reprod. Dev., 38, 107–117.
Stojdl DF, Lichty B, Knowles S, Marius R, Atkins H, Sonenberg N and Bell JC . (2000). Nat. Med., 6, 821–825.
Strong JE, Coffey MC, Tang D, Sabinin P and Lee PW . (1998). EMBO J., 17, 3351–3362.
Strong JE and Lee PW . (1996). J. Virol., 70, 612–616.
Strong JE, Tang D and Lee PW . (1993). Virology, 197, 405–411.
Tyler KL . (2001). Fields Virology, 4th edn. Knipe DM and Howley PM (eds). Lippincott-Raven: Philadelphia, PA, pp. 1729–1945.
Tzahar E and Yarden Y . (1998). Biochim. Biophys. Acta, 1377, M25–M37.
Ullrich A and Schlessinger J . (1990). Cell, 61, 203–212.
Waskiewicz AJ, Flynn A, Proud CG and Cooper JA . (1997). EMBO J., 16, 1909–1920.
Weiss A and Schlessinger J . (1998). Cell, 94, 277–280.
Wek RC . (1994). Trends Biochem. Sci., 19, 491–496.
White MA, Nicolette C, Minden A, Polverino A, Van AL, Karin M and Wigler MH . (1995). Cell, 80, 533–541.
White MA, Vale T, Camonis JH, Schaefer E and Wigler MH . (1996). J. Biol. Chem., 271, 16439–16442.
Willis AE . (1999). Int. J. Biochem. Cell Biol., 31, 73–86.
Wolthuis RM and Bos JL . (1999). Curr. Opin. Genet. Dev., 9, 112–117.
Yang WQ, Lun X, Palmer CA, Wilcox ME, Muzik H, Shi ZQ, Dyck R, Coffey M, Thompson B, Hamilton M, Nishikawa SG, Brasher PM, Fonseca K, George D, Rewcastle NB, Johnston RN, Stewart D, Lee PW, Senger DL and Forsyth PA . (2004). Clin. Cancer Res., 10, 8561–8576.
Yang WQ, Senger D, Muzik H, Shi ZQ, Johnson D, Brasher PM, Rewcastle NB, Hamilton M, Rutka J, Wolff J, Wetmore C, Curran T, Lee PW and Forsyth PA . (2003). Cancer Res., 63, 3162–3172.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shmulevitz, M., Marcato, P. & Lee, P. Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer. Oncogene 24, 7720–7728 (2005). https://doi.org/10.1038/sj.onc.1209041
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209041
Keywords
This article is cited by
-
Evaluating a combination treatment of NK cells and reovirus against bladder cancer cells using an in vitro assay to simulate intravesical therapy
Scientific Reports (2024)
-
Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
Molecular Cancer (2022)
-
Emerging systemic delivery strategies of oncolytic viruses: A key step toward cancer immunotherapy
Nano Research (2022)
-
Potentiating prostate cancer immunotherapy with oncolytic viruses
Nature Reviews Urology (2018)
-
Oncolytic virotherapy for urological cancers
Nature Reviews Urology (2016)